[Federal Register Volume 62, Number 113 (Thursday, June 12, 1997)]
[Notices]
[Page 32124]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 97-15318]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration


Manufacturer of Controlled Substances; Registration

    By Notice dated February 26, 1997, and published in the Federal 
Register on March 19, 1997, (62 FR 13170), Knoll Pharmaceuticals, 30 
North Jefferson Road, Whippany, New Jersey 07981, made application to 
the Drug Enforcement Administration (DEA) to be registered as a bulk 
manufacturer of hydromorphone (9150), a basic class of controlled 
substance listed in Schedule II.
    No comments or objections have been received. DEA has considered 
the factors in Title 21, United States Code, section 823(a) and 
determined that the registration of Knoll Pharmaceuticals to 
manufacture hydromorphone is consistent with the public interest at 
this time. Therefore, pursuant to 21 U.S.C. 823 and 28 CFR 0.100 and 
0.104, the Acting Deputy Assistant Administrator, Office of Diversion 
Control, hereby orders that the application submitted by the above firm 
for registration as a bulk manufacturer of the basic class of 
controlled substance listed above in granted.

    Dated: May 23, 1997.
Terrance W. Woodworth,
Acting Deputy Assistant Administrator, Office of Diversion Control, 
Drug Enforcement Administration.
[FR Doc. 97-15318 Filed 6-11-97; 8:45 am]
BILLING CODE 4410-09-M